However, using such biomarkers in combination with other markers, for example, cognitive (memory, executive function) and genetic (e.g., apolipoprotein E [APOE]) data, can increase the accuracy of a logistic regression‐based classification model in a cohort of participants with subjective cognitive decline and mild cognitive impairment (MCI).7 This evidence concerns the gene APOE and Cognitive impairment.